Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission
about
Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couplesPrevention of HIV-1 infection with early antiretroviral therapyCan one size fit all? Approach to bacterial vaginosis in sub-Saharan AfricaInfectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventionsEffectiveness of ART and condom use for prevention of sexual HIV transmission in serodiscordant couples: a systematic review and meta-analysisHIV, sexual violence and special populations: adolescence and pregnancyNonhuman primate models for HIV/AIDS vaccine developmentImpact of viral load and the duration of primary infection on HIV transmission: systematic review and meta-analysisOrigin of the transmitted virus in HIV infection: infected cells versus cell-free virusContraceptive methods and risk of HIV acquisition or female-to-male transmissionSemen CD4+ T cells and macrophages are productively infected at all stages of SIV infection in macaquesCare of the HIV-infected pregnant woman in the developed worldBottlenecks in HIV-1 transmission: insights from the study of founder virusesHerpes simplex virus-2 transmission probability estimates based on quantity of viral sheddingHIV-1 RNA levels and antiretroviral drug resistance in blood and non-blood compartments from HIV-1-infected men and women enrolled in AIDS clinical trials group study A5077Recent Insights into the HIV/AIDS Pandemic.An HIV epidemic model based on viral load dynamics: value in assessing empirical trends in HIV virulence and community viral loadGlycerol Monolaurate Microbicide Protection against Repeat High-Dose SIV Vaginal Challenge.Factors Driving the HIV Epidemic in Southern Africa.Condomless sex and HIV transmission among serodifferent couples: current evidence and recommendations.Systemic preexposure prophylaxis for HIV: translating clinical data to clinical practice.HIV-DNA in the genital tract of women on long-term effective therapy is associated to residual viremia and previous AIDS-defining illnesses.Presence of CD8+ T cells in the ectocervical mucosa correlates with genital viral shedding in HIV-infected women despite a low prevalence of HIV RNA-expressing cells in the tissue.Use of withdrawal (coitus interruptus) for both pregnancy and HIV prevention among young adults in Rakai, Uganda.Clinical and Mucosal Immune Correlates of HIV-1 Semen Levels in Antiretroviral-Naive Men.A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples.The semen microbiome and its relationship with local immunology and viral load in HIV infection.The effects of chronic binge alcohol on the genital microenvironment of simian immunodeficiency virus-infected female rhesus macaques.Impact of collection method on assessment of semen HIV RNA viral loadA prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy.Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract.HIV delays IFN-α production from human plasmacytoid dendritic cells and is associated with SYK phosphorylation.Reproductive assistance in HIV serodiscordant couples.HIV treatment as prevention: optimising the impact of expanded HIV treatment programmesHIV treatment as prevention: the utility and limitations of ecological observation.HIV-1 genital shedding is suppressed in the setting of high genital antiretroviral drug concentrations throughout the menstrual cycle.HIV-1 RNA may decline more slowly in semen than in blood following initiation of efavirenz-based antiretroviral therapySeminal plasma HIV-1 RNA concentration is strongly associated with altered levels of seminal plasma interferon-γ, interleukin-17, and interleukin-5.Drug-Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV
P2860
Q21144606-73492F15-B3A9-459D-B62C-15E6DE30399DQ24634688-A0DCC026-B09F-4F35-96AC-C15F905BC034Q26766261-0E5E79D2-04A9-499C-8F3C-39C270428D60Q26823594-E98D3255-7511-4E0C-9977-A074B8A2BBB5Q26824382-E491C65F-489B-445B-BBB7-66E0E014F01DQ26825943-90BA8781-FDA3-4E2D-B26C-DDDFC13C812CQ26861148-A7BE1FB5-CB38-4824-999E-9757C13CB400Q26861475-FA7A2FB6-3A42-429A-8B9A-CEAC02B51D51Q27021279-235380FA-FEC9-4D10-B78A-B847C32A37B5Q27027323-C9321B92-D51C-4125-B871-D175D5F46844Q27331721-12D9014C-C5E2-4811-8D93-6307C4053F3AQ28082774-882585AB-D9AF-4965-B9E9-67128995C95DQ28082862-D07414B9-639B-4953-8DF0-F98BB78E1D87Q28236882-F777EAC8-7F30-45F9-8D8C-A1FD4C9DF5F3Q28541918-7AEE05ED-FF36-46D2-ADDD-8293402764C2Q30235024-DAB4BA45-EFD2-4CA2-8E1E-F223799D5F83Q30363755-6DE47E0A-54A9-4BC1-8EE1-C245ED9E4BBDQ30375487-B999B967-91C0-43AC-95B9-9E818ABC4C45Q30387557-CEC4AFB3-C443-493F-8515-205E29144B31Q30401071-980C746E-32EF-466D-A6C3-98B8C2462E48Q30744184-6F03D610-9FB5-47D7-A74C-B6324316C787Q31130557-C18917D1-B358-4249-A0F9-97B74C76AA2BQ33390618-8EBD27B5-466C-4B64-B8FC-CE9D6E51AEF0Q33631016-ABA9FD59-107E-4AB8-A937-96B617FFC444Q33647158-10ED90BA-AE39-4C58-A284-ADA8769408E0Q33763511-57F28AAC-E45D-46D3-8EFC-9509D7FBEA8BQ33874874-0735520F-3125-41A4-BD8B-A8F147F75E4EQ33946146-4DF8A3BA-7DC0-4BB7-9BFE-4F89586A7E22Q33988160-8D092907-5490-4436-A644-D9E2DEBABEE1Q34008885-B8104979-7F06-4098-98E8-E1C91D4180F9Q34065082-975E0A4B-909A-4CB2-AEA6-D1C61864378BQ34295695-7B013B25-85A0-4D4B-AE1F-9FA3B4BAE13EQ34302303-F723F7EE-91FB-4194-B2DD-BD1A1A67DFCCQ34311329-0739F632-ED61-4787-9794-79663F62B801Q34339517-C8CF3BBC-0E9E-4CD4-9A1A-B9F914AF6E59Q34339533-56EAB0B8-C649-4B89-AB4A-B7A8357B2609Q34366639-A561CBEB-0C97-45A2-88A9-2E7898579EE8Q34389260-307435D0-C254-48E5-9CE3-E417E93BC471Q34399502-411E0968-9A8F-47F3-A59C-4902B216A99DQ34538556-FA40BEEE-5A15-4345-AE5A-3F8F6DF3152B
P2860
Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission
@ast
Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission
@en
Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission
@nl
type
label
Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission
@ast
Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission
@en
Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission
@nl
prefLabel
Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission
@ast
Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission
@en
Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission
@nl
P2093
P2860
P50
P1476
Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission
@en
P2093
Edith Nakku-Joloba
Erin Kahle
Jairam R Lingappa
James I Mullins
Jared M Baeten
Mary S Campbell
Nelly R Mugo
Partners in Prevention HSV/HIV Transmission Study Team
Robert W Coombs
P2860
P304
P356
10.1126/SCITRANSLMED.3001888
P407
P50
P577
2011-04-01T00:00:00Z